• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There are few data on how exposure to ADHD for a long time could affect a pregnant fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication should consider the benefits of taking it versus the risks for the fetus. Physicians don't have the data to provide clear recommendations but they can provide information about risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry concluded that women who took inattentive adhd medication uk medication in early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers used a vast population-based study of case-control to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy, as well as those who had not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to ensure that the classification was correct and to minimize any bias.

However, the study was not without its flaws. The most important issue was that they were unable to distinguish the effects of the medication from the effects of the disorder that is underlying. This limitation makes it difficult for researchers to establish whether the small differences observed between the groups that were exposed to the use of medications or affected by the presence of comorbidities. Additionally, the researchers did not study long-term offspring outcomes.

The study did show that babies whose mothers had taken ADHD medications during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had cut back on their medications prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the higher risk of admission did not appear to be influenced by which stimulant medications were used during pregnancy.

Women who took stimulant intuniv adhd medication medications during pregnancy also had a higher chance of having caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the small risk of using ADHD medications in early pregnancies can be offset by greater benefits genetic testing for adhd medications baby and mother of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies to improve their coping abilities that may minimize the negative impact of her condition on her daily life and relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and being treated with medication, the question of whether to keep or stop treatment during pregnancy is one that doctors are having to confront. The majority of these decisions are made without clear and authoritative evidence regardless, so doctors must weigh their knowledge, the experiences of other doctors, and what research suggests on the subject, along with their own best judgment for each individual patient.

Particularly, the subject of potential risks for the baby can be a challenge. Many studies on this issue are based on observational data rather than controlled research and their conclusions are often contradictory. Most studies limit their analysis to live births, which may underestimate the teratogenic impact which can cause terminations or abortions of pregnancy. The study presented in this journal club addresses these issues by analyzing data on live and deceased births.

Conclusion: While some studies have found an association between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show a neutral, or even slight negative impact. In each case, a careful evaluation of the potential risks and benefits must be performed.

For women suffering from ADHD, the decision to discontinue medication is difficult if not impossible. In fact, in an article recently published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. Additionally, the loss of medication can affect the ability to complete work-related tasks and safely drive, which are important aspects of daily life for many people with ADHD.

She recommends women who are unsure about whether to continue or stop medication in light of their pregnancy should consider informing family members, friends and colleagues on the condition, its impact on daily functioning, and on the advantages of staying on the current treatment regimen. It can also help women feel supported in her decision. It is important to note that some drugs can be absorbed through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug could be transferred to the child.

Risk of Birth Defects

As the use and misuse of ADHD medication for adhd and bipolar to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases as does the concern about the possible effects of the drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers utilized two massive data sets to examine more than 4.3 million pregnant women and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers of the study found no connection between early use of medication and congenital abnormalities such as facial clefting or club foot. The results are in the same vein as previous studies that have shown the existence of a slight, but significant increase in the number of cardiac malformations among women who began taking ADHD medication prior to pregnancy. This risk increased during the latter stages of pregnancy when many women began to stop taking their medication.

Women who used ADHD medications in the first trimester of pregnancy were also more likely to undergo caesarean section, low Apgar score following delivery, and a baby who required breathing assistance at birth. The researchers of the study could not remove bias in selection since they limited their study to women without other medical conditions that could have contributed to the findings.

The researchers hope their research will aid in the clinical decisions of doctors who see pregnant women. They recommend that, while the discussion of the benefits and risks is important but the decision to stop or continue treatment must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also advise that, while stopping the medication is an option, it isn't an option that is recommended due to the high incidence of depression and other mental health issues in women who are pregnant or post-partum. Furthermore, research suggests that women who choose to stop taking their medication are more likely to have difficulties adapting to life without them after the baby's arrival.

Nursing

It can be overwhelming to become a mother. Women with ADHD may face a lot of challenges when they must deal with their symptoms, go to doctor appointments, prepare for the birth of their child and adjust to a new routine. Many women choose to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk in low amounts. The rate of exposure to medication can vary depending upon the dosage the medication is administered, its frequency and the time of the day. In addition, different medications enter the baby’s system via the gastrointestinal tract, or through breast milk. The effect on the health of a newborn is not completely known.

Because of the lack of research, some physicians may recommend stopping stimulant drugs during the pregnancy of a woman. This is a difficult choice for the patient, who must balance the benefits of keeping her medication against the possible dangers to the fetus. As long as there is no more information, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal period.

A increasing number of studies have shown that women can continue to take their ADHD medication during pregnancy and while breastfeeding. This has led to many patients choose to do so and, in consultation with their physician, they have found that the benefits of keeping their current medication exceed any risk.

It is crucial for women suffering from ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation should also be provided to help women with adhd medication options recognize their symptoms and underlying disorder and learn about treatment options and reinforce existing strategies for coping. This should be an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and child, and monitoring for signs of deterioration and, if needed adjustments to the medication regime.